Attitude Towards Drug Therapy in a Community Mental Health Center Evaluated by the Drug Attitude Inventory

References

• World Health Organization. Adherence to long-term therapies. Evidence for action. Gineva: WHO; 2003. Available from: http://www.who.int/chp/knowledge/publications/adherence_report/en/. Accessed April 13, 2020.
   Google Scholar
• National Institute for Health and Clinical Excellence. Medicines adherence involving patients in decisions about prescribed medicines and supporting adherence. NICE clinical guideline n. 76; 2009. Available from: http://www.nice.org.uk/guidance/CG76. Accessed April 13, 2020.
   Google Scholar
• Williams A, Manias E, Walker R. Interventions to improve medication adherence in people with multiple chronic condition: a systematic review. J Adv Nurs. 2008;63(2):132–143. doi:10.1111/j.1365-2648.2008.04656.x
   PubMed Web of Science ®Google Scholar
• Sirois BC, Burg MM. Negative emotion and coronary heart disease. A review. Behav Modif. 2003;27(1):83–102. doi:10.1177/0145445502238695
   PubMed Web of Science ®Google Scholar
• Colivicchi F, Abrignani MG, Santini M. Aderenza terapeutica: il fattore di rischio occulto. [Therapeutic adherence: a hidden risk factor]. G Ital Cardiol. 2010;11(5 Suppl 3): 124S–127S. doi:10.1714/576.6834
   Google Scholar
• Baroletti S, Dell’Orfano H. Medication adherence in cardiovascular disease. Circulation. 2010;121(12):1455–1458. doi:10.1161/CIRCULATIONAHA.109.904003
   PubMed Web of Science ®Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497. doi:10.1056/NEJMra050100
   PubMed Web of Science ®Google Scholar
• Dunbar-Jacob J, Erlen JA, Schlenk EA, Ryan CM, Sereika SM, Doswell WM Adherence in chronic disease. Annu Rev Nurs Res. 2000;18:48–90. doi:10.1891/0739-6686.18.1.48
   PubMedGoogle Scholar
• Rybacki JJ. Improving cardiovascular health in postmenopausal women by addressing medication adherence issues. J Am Pharm Assoc. 2002;42(1):63–71. doi:10.1331/108658002763538099
   Google Scholar
• Semahegn A, Torpey K, Manu A, Assefa N, Tesfaye  G, Ankomah A. Psychotropic medication non-adherence and associated factors among adult patients with major psychiatric disorders: a protocol for a systematic review. Systematic Reviews. 2018;7:10. doi:10.1186/s13643-018-0676-y
   Google Scholar
• Balestrieri M, Bellantuono C, Berardi D, et al. Manuale di Psichiatria. [Manual of Psychiatry] Roma: Il Pensiero Scientifico Editore; 2014. Italian.
   Google Scholar
• Cramer JA, Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatr Serv. 1998;49(2):196–201. doi:10.1176/ps.49.2.196
   PubMed Web of Science ®Google Scholar
• Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry. 2002;63(10):892–909. doi:10.4088/JCP.v63n1007
   PubMed Web of Science ®Google Scholar
• Medina E, Salvà J, Ampudia R, Maurino J, Larumbe J. Short-term clinical stability and lack of insight are associated with a negative attitude towards antipsychotic treatment at discharge in patients with schizophrenia and bipolar disorder. Patient Prefer Adherence. 2012; 6:623–629. doi: 10.2147/PPA.S34345
   Web of Science ®Google Scholar
• Rossi A, Stratta P, Arduini A. Compliance with antipsychotic medication. Italian J Psychopathol. 2002;8(4):391–400.
   Google Scholar
• Klingberg S, Schneider S, Wittorf A, Buchkremer G, Wiedemann G. Collaboration in outpatient antipsychotic drug treatment: analysis of potentially influencing factors. Psychiatry Res. 2008;161(2):225–234. doi:10.1016/j.psychres.2007.07.027
   PubMed Web of Science ®Google Scholar
• Lauzier S, Grégoire JP, Lesage A, Moisan J. Community pharmacy loyalty among individuals with schizophrenia. Res Social Adm Pharm. 2013;9(6):806–816. doi:10.1016/j.sapharm.2013.01.007
   Web of Science ®Google Scholar
• Zipursky R, Menezes N, Streiner D. Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review. Schizophr Res. 2014;152:408–414. doi:10.1016/j.schres.2013.08.001.19
   PubMed Web of Science ®Google Scholar
• Di Lorenzo R, Cameli M, Piemonte C, et al. Clinical improvement, relapse and treatment adherence with paliperidone palmitate 1-month formulation: 1-year treatment in a naturalistic outpatient setting. Nord J Psychiatry. 2018;72(3):214–220. doi:10.1080/08039488.2017.1420819
   PubMed Web of Science ®Google Scholar
• Haddad PM, Brain C, Scott J. Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies. Patient Relat Outcome Meas. 2014;5:43–62. doi:10.2147/PROM.S42735
   PubMedGoogle Scholar
• Di Lorenzo R, Sagona M, Landi G, Martire L, Piemonte C, Del Giovane C. The revolving door phenomenon in an Italian acute psychiatric ward: a 5-year retrospective analysis of the potential risk factors. J Nerv Ment Dis. 2016;204(9):686–692. doi:10.1097/NMD.0000000000000540
   PubMed Web of Science ®Google Scholar
• Brain C, Allerby K, Sameby B, et al. Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS(®)) in the Swedish COAST-study. Eur Neuropsychopharmacol. 2013;23(12):1754–1762. doi:10.1016/j.euroneuro.2013.09.001
   Web of Science ®Google Scholar
• Ascher-Svanum H, Faries DE, Zhu B, Ernst FR, Swartz MS, Swanson JW. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. J Clin Psychiatry. 2006;67(3):453–460. doi:10.4088/JCP.v67n0317
   PubMed Web of Science ®Google Scholar
• Novick D, Haro JM, Suarez D, Perez V, Dittmann RW, Haddad PM. Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Res. 2010; 176(2–3):109–113. doi:10.1016/j.psychres.2009.05.004
   PubMed Web of Science ®Google Scholar
• Hayhurst KP, Drake RJ, Massie JA, et al. Improved quality of life over one year is associated with improved adherence in patients with schizophrenia. Eur Psychiatry. 2014;29(3):191–196. doi:10.1016/j.eurpsy.2013.03.002
   Web of Science ®Google Scholar
• Hong J, Reed C, Novick D, Haro JM, Aguado J. Clinical and economic consequences of medication non-adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) study. Psychiatry Res. 2011;190(1):110–114. doi:10.1016/j.psychres.2011.04.016
   PubMed Web of Science ®Google Scholar
• García S, Martínez-Cengotitabengoa M, López-Zurbano S, et al. Adherence to antipsychotic medication in bipolar disorder and schizophrenic patients. A systematic review. J Clin Psychopharmacol. 2016;36(4):355–371. doi:10.1097/JCP.0000000000000523
   PubMed Web of Science ®Google Scholar
• De Las Cuevas C, Peñate W, Manuel García de Cecilia J, de Leon J. Predictive validity of the Sidorkiewicz instrument in Spanish: assessing individual drug adherence in psychiatric patients. Int J Clin Health Psychol. 2018;18(2):133–142. doi:10.1016/j.ijchp.2017.11.003
   Web of Science ®Google Scholar
• Velligan DI, Sajatovic M, Hatch A, Kramata P, Docherty JP. Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness. Patient Prefer Adherence. 2017;11:449–468. doi:10.2147/PPA.S124658
   PubMed Web of Science ®Google Scholar
• Baloush-Kleinman V, Levine SZ, Roe D, Shnitt D, Weizman A, Poyurovsky M. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study. Schizophr Res. 2011;130 (1–3):176–181. doi:10.1016/j.schres.2011.04.030
   PubMed Web of Science ®Google Scholar
• Mohamed S, Rosenheck R, McEvoy J, Swartz M, Stroup S, Lieberman JA. Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia. Schizophr Bull. 2009;35(2):336–346. doi:10.1093/schbul/sbn067
   PubMed Web of Science ®Google Scholar
• Beck EM, Cavelti M, Kvrgic S, Kleim B, Vauth R. Are we addressing the ‘right stuff’ to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication. Schizophr Res. 2011;132(1):42–49. doi:10.1016/j.schres.2011.07.019
   PubMed Web of Science ®Google Scholar
• Wong MM, Chen EY, Lui SS, Tso S. Medication adherence and subjective weight perception in patients with first-episode psychotic disorder. Clin Schizophr Relat Psychoses. 2011;5(3):135–141. doi:10.3371/CSRP.5.3.3
   PubMedGoogle Scholar
• Kamali M, Kelly BD, Clarke M, et al. A prospective evaluation of adherence to medication in first episode schizophrenia. Eur Psychiatry. 2006;21(1):29–33. doi:10.1016/j.eurpsy.2005.05.015
   PubMed Web of Science ®Google Scholar
• Ascher-Svanum H, Zhu B, Faries D, Lacro JP, Dolder CR. A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia. J Clin Psychiatry. 2006;67(7):1114–1123. doi:10.4088/JCP.v67n0715
   Web of Science ®Google Scholar
• González-Pinto A, Reed C, Novick D, Bertsch J, Haro JM. Assessment of medication adherence in a cohort of patients with bipolar disorder. Pharmacopsychiatry. 2010;43(7):263–270. doi:10.1055/s-0030-1263169
   PubMed Web of Science ®Google Scholar
• Miller R, Ream G, McCormack J, Gunduz-Bruce H, Sevy S, Robinson D. A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia. Schizophr Res. 2009;113(2–3):138–144. doi:10.1016/j.schres.2009.04.018
   PubMed Web of Science ®Google Scholar
• Rabinovitch M, Béchard-Evans L, Schmitz N, Joober R, Malla A. Early predictors of nonadherence to antipsychotic therapy in first-episode psychosis. Can J Psychiatry. 2009;54(1):28–35. doi:10.1177/070674370905400106
   PubMed Web of Science ®Google Scholar
• Magura S, Rosenblum A, Fong C. Factors associated with medication adherence among psychiatric outpatients at substance abuse risk. Open Addict J. 2011;4:58–64. doi:10.2174/1874941001104010058
   PubMedGoogle Scholar
• Sapra M, Weiden PJ, Schooler NR, Sunakawa-McMillan A, Uzenoff S, Burkholder P. Reasons for adherence and nonadherence: a pilot study comparing first- and multi-episode schizophrenia patients. Clin Schizophr Relat Psychoses. 2014;7(4):199–206. doi:10.3371/CSRP.SAWE.020813
   PubMedGoogle Scholar
• Lee Y, Lee MS, Jeong HG, Youn HC, Kim SH. Medication Adherence Using Electronic Monitoring In Severe Psychiatric Illness: 4 and 24 weeks after discharge. Clin Psychopharmacol Neurosci. 2019;17(2):288–296. doi:10.9758/cpn.2019.17.2.288
   PubMed Web of Science ®Google Scholar
• Tessier A, Boyer L, Husky M, Baylé F, Llorca PM, Misdrahi D. Medication adherence in schizophrenia: the role of insight, therapeutic alliance and perceived trauma associated with psychiatric care. Psychiatry Res. 2017;257:315–321. doi:10.1016/j.psychres.2017.07.063
   PubMed Web of Science ®Google Scholar
• Barkhof E, Meijer CJ, de Sonneville LM, Linszen DH, de Haan L. Interventions to improve adherence to antipsychotic medication in patients with schizophrenia–a review of the past decade. Eur Psychiatry. 2012;27(1):9–18. doi:10.1016/j.eurpsy.2011.02.005
   PubMed Web of Science ®Google Scholar
• Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med. 1983;13(1):177–183. doi:10.1017/S0033291700050182
   PubMed Web of Science ®Google Scholar
• Rossi A, Arduini L, De Cataldo S, Stratta P. Subjective response to neuroleptic medication: a validation study of the Italian version of the Drug Attitude Inventory (DAI). Epidemiol Psichiatr Soc. 2001;10(2):107–114. doi:10.1017/S1121189X00005182
   Google Scholar
• Yoon BH, Bahk WM, Lee KU, Hong CH, Ahn JK, Kim MK. Psychometric properties of Korean version of drug attitude inventory (KDAI-10). Korean J Psychopharmacol. 2005;16(6):480–487. Korean.
   Google Scholar
• Aydin E, Aydin E, Balaban ÖD, Yumrukçal H, Erkiran M. The validity and reliability of the Turkish version of drug attitude inventory-10. Noro Psikiyatr Ars. 2018;55(3):238–242. doi:10.5152/npa.2017.18078
   Google Scholar
• Khalil AH, ELNahas G, Ramy H, Abdel Aziz K, Elkholy H, El-Ghamry R. Impact of a culturally adapted behavioural family psychoeducational programme in patients with schizophrenia in Egypt. Int J Psychiatry Clin Pract. 2019;23(1):62–71. doi:10.1080/13651501.2018.1480786
   PubMed Web of Science ®Google Scholar
• Nakhli J, Amamou B, Mlika S, et al. Cultural translation and Tunisian validation of the Drug Attitude Inventory (DAI-30) in outpatients with schizophrenia. Compr Psychiatry.2015;56:69–74. doi:10.1016/j.comppsych.2014.09.002
   Web of Science ®Google Scholar
• Townsend L, Floersch J, Findling RL. Adolescent attitudes toward psychiatric medication: the utility of the Drug Attitude Inventory. J Child Psychol Psychiatry. 2009;50(12):1523–1531. doi:10.1111/j.1469-7610.2009.02113.x
   Web of Science ®Google Scholar
• Balestrieri M, Di Sciascio G, Isola M, et al. Drug attitude and subjective well-being in antipsychotic treatment monotherapy in real-world settings. Epidemiol Psichiatr Soc. 2009;18(2):114–118. doi:10.1017/S1121189X00000993
   Google Scholar
• Dassa D, Boyer L, Benoit M, Bourcet S, Raymondet P, Bottai T. Factors associated with medication non-adherence in patients suffering from schizophrenia: a cross-sectional study in a universal coverage health-care system. Aust N Z J Psychiatry. 2010;44(10):921–928. doi:10.3109/00048674.2010.493503
   PubMed Web of Science ®Google Scholar
• Dahan S, Behrbalk P, Stolovy T, Greenberger C. Improving adherence in hospitalized patients diagnosed with schizophrenia: an integrative one-on-one intervention. Arch Psychiatr Nurs. 2016;30(6):660–665. doi:10.1016/j.apnu.2016.03.002
   Web of Science ®Google Scholar
• Ministry of Labor, Health and Social Policies. Classification of Diseases, Traumatisms, Surgical Interventions and Diagnostic and Therapeutic Procedures: Italian Version of the ICD-9-CM (International Classification of Diseases, 9th Revision, Clinical Modification, 2007). Rome: Istituto poligrafico e Zecca dello Stato, Libreria dello Stato; 2008.
   Google Scholar
• Crawford CB, Ferguson GA. A general rotation criterion and its use in orthogonal rotation. Psychometrika. 1970;35(3):321–332. doi:10.1007/BF02310792
   Web of Science ®Google Scholar
• Bentler PM. Factor simplicity index and transformations. Psychometrika. 1977;42(2):277–295. doi:10.1007/BF02294054
   Web of Science ®Google Scholar
• Kaiser HF. The varimax criterion for analytic rotation in factor analysis. Psychometrika. 1958;23:187–200. doi:10.1007/BF02289233
   Web of Science ®Google Scholar
• Kaiser HF. An index of factorial simplicity. Psychometrika. 1974;39(1):31–36. doi:10.1007/BF02291575
   Web of Science ®Google Scholar
• Tabachnick BG, Fidell LS. Using Multivariate Statistics. Boston: Pearson/Allyn & Bacon; 2007.
   Google Scholar
• Bryant FB, Yarnold PR. Principal-components analysis and exploratory and confirmatory factor analysis. In: Grimm G, RR Y, editors. Reading and Understanding Multivariate Statistics. Washington, DC, US: American Psychological Association; 1995.
   Google Scholar
• Thunander Sundbom L, Bingefors K, Hedborg K, Isacson D. Are men under-treated and women over-treated with antidepressants? Findings from a cross-sectional survey in Sweden. BJPsych Bull. 2017;41(3):145–150. doi:10.1192/pb.bp.116.054270
   PubMed Web of Science ®Google Scholar
• Maust DT, Lin LA, Blow FC. Benzodiazepine use and misuse among adults in the United States. Psychiatr Serv. 2019;70(2):97–106. doi:10.1176/appi.ps.201800321
   PubMed Web of Science ®Google Scholar
• Rej S, Schuurmans J, Elie D, Stek ML, Shulman K, Dols A. Attitudes towards pharmacotherapy in late-life bipolar disorder. Int Psychogeriatr. 2016;28(6):945–950. doi:10.1017/S1041610215002380
   Web of Science ®Google Scholar
• Barbui C, Papola D, Saraceno B. Forty years without mental hospitals in Italy. Int J Ment Health Syst. 2018;12:43. doi:10.1186/s13033-018-0223-1
   Web of Science ®Google Scholar
• Day JC, Bentall RP, Roberts C, et al. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Arch Gen Psychiatry. 2005;62(7):717–724. doi:10.1001/archpsyc.62.7.717
   PubMed Web of Science ®Google Scholar
• Scott KM, Wells JE, Angermeyer M, et al. Gender and the relationship between marital status and first onset of mood, anxiety and substance use disorders. Psychol Med. 2010;40(9):1495–1505. doi:10.1017/S0033291709991942
   PubMed Web of Science ®Google Scholar
• Biotteau AL, Bonnet C, Cambois E. Risk of major depressive episodes after separation: the gender-specific contribution of the income and support lost through union dissolution. Eur J Popul. 2019;35(3):519–542. doi:10.1007/s10680-018-9488-y
   Web of Science ®Google Scholar
• De Las Cuevas C, Peñate W, Sanz EJ. Risk factors for non-adherence to antidepressant treatment in patients with mood disorders. Eur J Clin Pharmacol. 2014;70(1):89–98. doi:10.1007/s00228-013-1582-9
   PubMed Web of Science ®Google Scholar
• Lehman AF, Lieberman JA, Dixon LB, et al. American Psychiatric Association; Steering Committee on Practice Guidelines. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry. 2004;161(2 Suppl):1–56.
   PubMed Web of Science ®Google Scholar
• Miller AL, Craig CS. Combination antipsychotics: pros, cons, and questions. Schizophr Bull. 2002;28(1):105–109. doi:10.1093/oxfordjournals.schbul.a006912
   PubMed Web of Science ®Google Scholar
• Lochmann van Bennekom MW, Gijsman HJ, Zitman FG. Antipsychotic polypharmacy in psychotic disorders: a critical review of neurobiology, efficacy, tolerability and cost effectiveness. J Psychopharmacol. 2013;27(4):327–336. doi:10.1177/0269881113477709
   PubMed Web of Science ®Google Scholar
• Tiihonen J, Taipale H, Mehtälä J, Vattulainen P, Correll CU, Tanskanen A. Association of antipsychotic polypharmacy vs monotherapy with psychiatric rehospitalization among adult with schizophrenia. JAMA Psychiatry. 2019;76(5):499–507. doi:10.1001/jamapsychiatry.2018.4320
   PubMed Web of Science ®Google Scholar
• Taylor DM, Barnes TRE, Young AH. The Maudsley Prescribing Guidelines in Psychiatry. 13th ed. UK: Wiley Blackwell; 2018.
   Google Scholar
• Riefolo G. Psichiatria prossima. La psichiatria territoriale in un'epoca di crisi. [Next psychiatry. The community psychiatry in a period of crisis]. Torino:Boringhieri Bollati Editore; 2001. Italian.
   Google Scholar
• Kikkert MJ, Dekker J. Medication adherence decisions in patients with schizophrenia. Prim Care Companion CNS Disord. 2017;19(6). pii:17n02182. doi:10.4088/PCC.17n02182
   Google Scholar
• Bonavigo T, Sandhu S, Pascolo-Fabrici E, Priebe S. What does dependency on community mental health services mean? A conceptual review with a systematic search. Soc Psychiatry Psychiatr Epidemiol. 2016;51:561–574. doi:10.1007/s00127-016-1180-0
   PubMed Web of Science ®Google Scholar